2 completed, 2 terminated, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow MD1003: new trials by email Literature Review of MD1003 trials Research Report on MD1003
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects MD1003, Moxifloxacin 400mg, Placebo for MD1003 - Healthy Volunteers | Phase 1 | Unknown | MedDay Pharmaceuticals SA | 64 | 2019-11-11 | 2020-02-20 |
| HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Hepatic Impairment of Moderate Child Pugh Category | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 15 | 2019-10-11 | 2020-05-13 |
| RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Impaired Renal Function | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 24 | 2019-10-09 | 2020-05-13 |
| SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study MD1003 - Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy | Phase 2 | Completed | MedDay Pharmaceuticals SA | 15 | 2016-12-05 | 2020-11-02 |
| Effect of MD1003 in Amyotrophic Lateral Sclerosis MD1003, Placebo oral capsule - ALS, Amyotrophic Lateral Sclerosis | Phase 2 | Completed | MedDay Pharmaceuticals SA | 30 | 2016-06-29 | 2019-06-04 |
Amyotrophic Lateral Sclerosis (1) · Charcot-Marie-Tooth Disease (1) · Motor Neuron Disease (1) · Peripheral Nervous System Diseases (1) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1) · Renal Insufficiency (1)
France (4) · Hungary (2) · United Kingdom (1)
Yves Donazzolo, MD (2) · Frederic Sedel, MD (1) · Muna Albayaty, MD (1)
2019 (2)